Enterprise Value
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary
- IMGN enterprise value is not available.
Performance
IMGN Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
IMGN Enterprise Value Trends
PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
---|---|---|---|
6 m6 months | - | - | - |
1 y1 year | - | - | - |
5 y5 years | - | - | - |
IMGN Enterprise Value Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | ||||
3 m | 3-month | ||||
6 m | 6-month | ||||
1 y | 1-year | $7.80 B | $7.39 B | ||
3 y | 3-year | $7.80 B | $275 M | ||
5 y | 5-year | $7.80 B | $220 M | ||
alltime | all time | $7.80 B | $17 M |
ImmunoGen Enterprise Value History
Date | Value |
---|---|
2023 | $7.39 B(+776.7%) |
2022 | $843.21 M(-28.2%) |
2021 | $1.18 B(+19.0%) |
2020 | $987.77 M(+59.9%) |
2019 | $617.82 M(+35.2%) |
2018 | $456.93 M(-21.8%) |
2017 | $584.43 M(+640.8%) |
2016 | $78.89 M(-91.9%) |
2015 | $968.85 M(+131.5%) |
2014 | $418.49 M(-61.2%) |
2013 | $1.08 B(+25.0%) |
2012 | $862.38 M(+19.8%) |
2011 | $719.78 M(+43.5%) |
2010 | $501.43 M(+25.6%) |
2009 | $399.24 M(+121.2%) |
2008 | $180.47 M(+8.9%) |
Date | Value |
---|---|
2007 | $165.67 M(-19.6%) |
2006 | $205.94 M(+0.9%) |
2005 | $204.06 M(-42.4%) |
2004 | $353.99 M(+81.1%) |
2003 | $195.46 M(+60.4%) |
2002 | $121.84 M(-81.1%) |
2001 | $645.53 M(-5.5%) |
2000 | $682.97 M(+345.8%) |
1999 | $153.19 M(+184.4%) |
1998 | $53.87 M(+198.0%) |
1997 | $18.08 M(-53.4%) |
1996 | $38.79 M(+15.4%) |
1995 | $33.62 M(-65.0%) |
1993 | $95.94 M(+8.9%) |
1992 | $88.12 M(+32.6%) |
1990 | $66.47 M |
FAQ
- What is the all time high enterprise value for ImmunoGen?
What is the all time high enterprise value for ImmunoGen?
ImmunoGen all-time high enterprise value is $7.80 B